Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMAERO LTD Director's Dealing 2023

Nov 5, 2023

64254_rns_2023-11-05_1a632407-8fa6-42d8-81e8-07d9411b6e05.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Amaero International Limited ABN 82 633 541 634

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Bob Latta
Date of last notice 5 September 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct & Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
1) Pegasus Growth Capital Fund I
Mr Latta is a partner of Pegasus
Growth Capital and holds a minority
interest in the shares held by
Pegasus Growth Capital Fund in
Amaero International Limited. Mr
Latta and his spouse have an indirect
beneficial interest in approximately
4.7% of Pegasus’ total shares; and
2) Robert Latta
Date of change 31 October 2023
No. of securities held prior to change 163,524,968 Fully Paid Ordinary Shares
(indirect beneficial interest of 4.7% of these
shares held by Pegasus)
Class Option Expiring 31-OCT-2033 ex $0.190
Number acquired 500,000 Options
Number disposed Nil
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
Nil consideration
No. of securities held after change 1) 163,524,968 Fully Paid Ordinary
Shares (indirect beneficial interest of
4.7% of these shares held by
Pegasus); and
2) 500,000 Options Expiring 31 October
2033, Ex. $0.190.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Options issued for nil consideration under the
Employee Incentive Plan and approved by
shareholders at the Annual General Meeting
held on 31 October 2023.
A further 500,000 Options will be issued once
exercise price is determined. For details,
please refer to the 2023 Notice of Annual
General
Meeting
and
Explanatory
Memorandum.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
N/A
Interest after change N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts
detailed above traded during a+closed period
where prior written clearance was required?
No
If so, was prior written clearance provided to allow
the trade to proceed during this period?
N/A
If prior written clearance was provided, on what
date was this provided?
N/A
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3